View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
Parent RIN:   1117-AA52
DOJ/DEA RIN: 1117-AA81 Publication ID: Fall 2000 
Title: Threshold for Gamma-Butyrolactone 
Abstract: Public Law 106-172,signed into law on February 18, 2000, and known as the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 1999" amends section 102(34) of the Controlled Substance Act as amended (CSA) by designating gamma-butyrolactone (GBL), the precursor to gamma-hydroxybutyric acid (GHB), as a List I chemical. Reflecting this change in stature, the Drug Enforcement Administration (DEA) is amending its regulation to reflect the status of GBL as a List I chemical subject to the requirements of the CSA and its regulations. Establishments of a threshold for GBL will be the subject of a separate rulemaking. Therefore, unless and until a threshold is established, any distribution of GBL is a regulated transaction as described by 21 CFR 1300.02(b)(28). All handlers of GBL must comply with the CSA regulatory requirements pertaining to List I chemicals as described in the body of this document. 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1310   
Legal Authority: 21 USC 802    21 USC 830    21 USC 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  04/00/2001    
NPRM Comment Period End  06/00/2001    
Additional Information: DEA-199, DEA-203
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Related RINs: Related to 1117-AA64 
Agency Contact: